CHINA NATIONAL MEDICINES CORPORATION LTD.

China National Medicines Corporation Ltd.

600511

CNE000001D56

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-05-27 EDT			5-day change	1st Jan Change
34.51 ^CNY	-1.99%		-2.15%	+20.58%

04-25	China National Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-21	China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings	MT

China National Medicines Corporation Ltd. Approves Appointment of Cai Jingchuan as Deputy General Manager

February 07, 2013 at 02:00 am

China National Medicines Corporation Ltd. approved the appointment of Cai Jingchuan as Deputy General Manager, at the directorate meeting on February 6, 2013.

Latest news about China National Medicines Corporation Ltd.

China National Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings	03-21	MT
Sinopharm's 2023 Profit Climbs 9%; Shares Up 6%	03-21	MT
China National Medicines Corporation Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-20	CI
China National Medicines Deputy Manager Under Probe for Alleged Insider Trading	01-10	MT
CASI Pharmaceuticals, Inc. Enters into an Exclusive Distribution Agreement with China National Medicines Corporation Ltd	12-08	CI
China National Medicines' Profit Drops 16.1% in Q3	23-10-25	MT
China National Medicines Corporation Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Sinopharm CFO Retires; Successor Named	23-10-16	MT
China National Medicines Corporation Ltd.(XSSC:600511) added to S&P Global BMI Index	23-09-18	CI
China National Medicines Corporation Ltd.(XSSC:600511) added to FTSE All-World Index	23-09-18	CI
China National Medicines' Profit Climbs 14.2% in H1	23-08-24	MT
China National Medicines Corporation Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI
China National Medicines' Q1 Profit Rises 10.9%	23-04-25	MT
China National Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Sinopharm’s Profit Rises 12% in 2022; Revenue Slips 2%	23-03-23	MT
China National Medicines' 2022 Profit Up 12%	23-03-23	MT
Sinopharm Eyes Production of Merck's COVID-19 Drug in China	23-01-13	MT
Sinopharm Clarifies It Is Not A Distributor for Pfizer's COVID-19 Drug	22-12-20	MT
Sinopharm to Buy $168 Million Shares in Shyndec Pharma	22-11-30	MT
Sinopharm Unit Wins Nod to Launch Clinical Trial of COVID-19 Nasal Drug	22-11-29	MT
China National Medicines' Q3 Profit Rises 6%	22-10-23	MT
China National Medicines Corporation Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-21	CI
China National Medicines Unit Isolates Monkeypox Virus, Begins Vaccine Development	22-10-21	MT
China National Medicines' H1 Net Profit Rises 13%	22-08-25	MT

Chart China National Medicines Corporation Ltd.

Duration

Period

Chart China National Medicines Corporation Ltd.

More charts

China National Medicines Corporation Ltd. is a China-based company principally engaged in the distribution of pharmaceutical products. The Company's primary products include proprietary Chinese medicines, chemical medicine preparations, chemical raw materials, antibiotics, biochemical drugs, biological products, narcotic drugs, psychotropic drugs, vaccines and health foods, among others. The Company is also involved in the production of pharmaceuticals and the provision of warehousing services through its subsidiaries.

Sector

Pharmaceuticals

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for China National Medicines Corporation Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

34.51 CNY

Average target price

44.3 CNY

Spread / Average Target

+28.37%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
CHINA NATIONAL MEDICINES CORPORATION LTD.	+20.58%	3.59B
MCKESSON CORPORATION	+18.64%	71.4B
CARDINAL HEALTH, INC.	-6.00%	23.08B
SINOPHARM GROUP CO. LTD.	+3.42%	8.55B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+9.32%	8.43B
HUADONG MEDICINE CO., LTD	-25.47%	7.46B
H. LUNDBECK A/S	+13.37%	5.23B
EBOS GROUP LIMITED	+1.58%	4.29B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+5.71%	3.89B
GALENICA AG	+0.76%	4.03B

Pharmaceuticals Wholesale